|
2025
|
Invention
|
Measuring eye refraction.
Methods, systems, and devices are provided for measuring eye refractio... |
|
2024
|
Invention
|
Compositions and methods of fas inhibition.
Described are compositions and methods for preventin... |
|
|
Invention
|
Blood biomarkers and diagnostic methods for small vessel diseases.
The present subject matter pr... |
|
|
Invention
|
Adenovirus helper plasmid and stable helper cell line for aav production and uses thereof. Provid... |
|
|
Invention
|
Low oxygen culture conditions for maintaining retinal progenitor cell multipotency.
The present ... |
|
|
Invention
|
Nucleic acid encoded runx3 transcription factor. The present invention is inter alia directed to ... |
|
|
Invention
|
Systems and methods to determine and control distribution of digital content. A system (100) may ... |
|
|
Invention
|
Nucleic acid-based compositions and methods for treating small vessel diseases.
The present subj... |
|
|
Invention
|
Dscam inhibitory nucleic acids and methods of use thereof. The disclosure features compositions a... |
|
|
Invention
|
Methods of treating age-related macular degeneration targeting igfbpl-1. Described are methods fo... |
|
|
Invention
|
Altering tissue tropism of adeno-associated viruses.
This disclosure provides compositions and m... |
|
|
Invention
|
Phenotype profile of human retinal progenitor cells.
The present invention relates to substantia... |
|
|
Invention
|
Methods of preserving vision and treating vision loss. DNMT3A DNMT3A DNMT3A inhibitory nucleic ac... |
|
|
Invention
|
Measuring dark adaptation.
Methods, systems, and devices are provided for measuring dark adaptat... |
|
|
Invention
|
Measuring eye refraction. Methods, systems, and devices are provided for measuring eye refraction... |
|
2023
|
Invention
|
Secreted phosphoprotein 1 (spp1) as a neuroprotective therapy in neurodegenerative disease. Provi... |
|
|
Invention
|
Methods for treating dry eye disease.
Methods to treat dry eye disease and to slow, inhibit or d... |
|
|
Invention
|
Methods for treating dry eye disease. Methods to treat dry eye disease and to slow, inhibit or de... |
|
|
Invention
|
Therapy for glaucoma and optic neuropathy by targeting colony stimulating factors. The invention ... |
|
|
Invention
|
Isolation, enrichment, and expansion of human rod progenitor cells and extracellular vesicles der... |
|
|
Invention
|
Electrospun reinforced suturable artificial cornea and uses thereof.
An implant and method of fa... |
|
|
Invention
|
Methods of predicting ancestral virus sequences and uses thereof. Methods are described for predi... |
|
|
Invention
|
Methods for preserving visual function using ramp waveform electrical stimulation.
Provided here... |
|
|
Invention
|
Methods for preserving visual function using ramp waveform electrical stimulation. Provided herei... |
|
|
Invention
|
Topotecan for proliferative vitreoretinopathy.
The use of topotecan, e.g., repeated dosing or su... |
|
|
Invention
|
Compositions and methods for gene therapy for corneal endothelium disorders.
This application di... |
|
|
Invention
|
Nucleic acid encoded transcription factor inhibitors.
The present invention is inter alia direct... |
|
|
Invention
|
Nucleic acid encoded transcription factor inhibitors. The present invention is inter alia directe... |
|
2022
|
Invention
|
Compositions for the treatment of dry eye and methods of use thereof.
The disclosure relates to ... |
|
|
Invention
|
Methods of reducing severity of glaucoma by intravitreal administration of insulin-like growth fa... |
|
|
Invention
|
Blood biomarkers and diagnostic methods for small vessel diseases. The present subject matter pro... |
|
|
Invention
|
Stimulation of human meibomian gland function.
Disclosed herein are systems and methods for stim... |
|
|
Invention
|
Notch3 agonist compositions and methods for treating small vessel diseases.
The present subject ... |
|
|
Invention
|
Novel methods of using adeno-associated virus 11 (aav11).
The present application relates to com... |
|
|
Invention
|
Novel methods of using adeno-associated virus 11 (aav11). The present application relates to comp... |
|
|
Invention
|
Methods for treating neurodegeneration targeting igf1/igf1r.
Described are methods for the treat... |
|
|
Invention
|
Optimized aav-based vaccine.
The present application relates to compositions and methods for eli... |
|
|
Invention
|
Optimized aav-based vaccine. The present application relates to compositions and methods for elic... |
|
|
Invention
|
Methods and compositions for modulating the interaction between adeno-associated virus (aav) and ... |
|
2021
|
Invention
|
Methods and compositions for the treatment of corneal endothelium disorders.
This application di... |
|
|
Invention
|
Compositions and methods for mucosal drug delivery.
Disclosed herein are polymers, nanoparticles... |
|
|
Invention
|
Methods and compositions for restricting biodistribution of aav.
The present disclosure relates ... |
|
|
Invention
|
Rho kinase inhibition for treatment of proliferative vitreoretinopathy and conditions associated ... |
|
|
Invention
|
Methods and materials for treatment of fibrosis.
Described herein are methods for treating and r... |
|
|
Invention
|
Methods of making and using a vaccine against coronavirus.
Provided herein are vaccines against ... |
|
2020
|
Invention
|
Predicting clinical parameters relating to glaucoma from central visual field patterns.
Systems ... |
|
|
Invention
|
Isolation, enrichment and expansion of cone progenitor cells and uses thereof.
Progenitor cells ... |
|
2019
|
Invention
|
Altering tissue tropism of adeno-associated viruses. This disclosure provides compositions and me... |
